Skip to content

Clinical study for evaluation of curative effect of traditional Chinese medicine combined with clustering multiple organ support therapy in the treatment of patients with sepsis

Clinical study for evaluation of curative effect of traditional Chinese medicine combined with clustering multiple organ support therapy in the treatment of patients with sepsis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026023
Enrollment
Unknown
Registered
2019-09-18
Start date
2019-10-31
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Integrated Chinese and Western Medicine Treatment Group:On the basis of traditional Chinese medicine treatment, combined with Western medicine for clustering multiple organ support treatment
Western medicine routine treatment group:cluster organ support treatment

Sponsors

Shanghai General Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
28 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, = 2 points, ie ?SOFA score >= 2 points; (Unknown patients with organ dysfunction have a baseline SOFA score of 0); 4. Chinese medicine syndrome differentiation is hot poison flaming; 5. Patient informed consent.

Exclusion criteria

Exclusion criteria: 1. Can not eat normally and indwelling stomach / jejunal nutrition tube loser; 2. No history of malignant solid tumors, hematological tumors, autoimmune diseases, etc. that have been transferred and cannot be removed; 3. Hematopoietic stem cell transplantation, liver, kidney, lung, pancreas and other physical organ transplantation history; 4. Estimated survival time < 24 hours; 5. Pregnant or breast-feeding patients; 6. Those who are allergic to the Chinese herbal medicine in this study.

Design outcomes

Primary

MeasureTime frame
28-Day All-Cause Mortality;

Secondary

MeasureTime frame
organ no-support time within 28 days;hospitalization time in ICU and total length of stay within 28 days;Indicators of organ function;Types and incidence of adverse events;

Countries

China

Contacts

Public ContactLiu Jun

Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

Ljswj_2006@163.com+86 13701952725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026